Cited by 616Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases

Open access

Lanoiselée, Hélène-Marie, Nicolas, Gaël, Wallon, David, Rovelet-Lecrux, Anne, Lacour, Morgane, Rousseau, Stéphane, Richard, Anne-Claire, Pasquier, Florence, Rollin-Sillaire, Adeline, Martinaud, Olivier, Quillard-Muraine, Muriel, de la Sayette, Vincent, Boutoleau-Bretonniere, Claire, Etcharry-Bouyx, Frédérique, Chauviré, Valérie, Sarazin, Marie, le Ber, Isabelle, Epelbaum, Stéphane, Jonveaux, Thérèse, Rouaud, Olivier, Ceccaldi, Mathieu, Félician, Olivier, Godefroy, Olivier, Formaglio, Maite, Croisile, Bernard, Auriacombe, Sophie, Chamard, Ludivine, Vincent, Jean-Louis, Sauvée, Mathilde, Marelli-Tosi, Cecilia, Gabelle, Audrey, Ozsancak, Canan, Pariente, Jérémie, Paquet, Claire, Hannequin, Didier, Campion, Dominique, collaborators of the CNR-MAJ project·2017·PLOS Medicine

DOI 10.1371/journal.pmed.1002270PMC PMC5370101

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Amyloid protein precursor (APP), presenilin-1 (PSEN1), and presenilin-2 (PSEN2) mutations cause autosomal dominant forms of early-onset Alzheimer disease (AD-EOAD). Although these genes were identified in the 1990s, variant classification remains a challenge, highlighting the need to colligate mutations from large series. METHODS AND FINDINGS: We report here a novel update (2012-2016) of the genetic screening of the large AD-EOAD series ascertained across 28 French hospitals from 1993 onwards, bringing the total number of families with identified mutations to n = 170. Families were included when at least two first-degree relatives suffered from early-onset Alzheimer disease (EOAD) with an age of onset (AOO) ≤65 y in two generations. Furthermore, we also screened 129 sporadic cases of Alzheimer disease with an AOO below age 51 (44% males, mean AOO = 45 ± 2 y). APP, PSEN1, or PSEN2 mutations were identified in 53 novel AD-EOAD families. Of the 129 sporadic cases screened, 17 carried a PSEN1 mutation and 1 carried an APP duplication (13%). Parental DNA was available for 10 sporadic mutation carriers, allowing us to show that the mutation had occurred de novo in each case. Thirteen mutations (12 in PSEN1 and 1 in PSEN2) identified either in familial or in sporadic cases were previously unreported. Of the 53 mutation carriers with available cerebrospinal fluid (CSF) biomarkers, 46 (87%) had all three CSF biomarkers-total tau protein (Tau), phospho-tau protein (P-Tau), and amyloid β (Aβ)42-in abnormal ranges. No mutation carrier had the three biomarkers in normal ranges. One limitation of this study is the absence of functional assessment of the possibly and probably pathogenic variants, which should help their classification. CONCLUSIONS: Our findings suggest that a nonnegligible fraction of PSEN1 mutations occurs de novo, which is of high importance for genetic counseling, as PSEN1 mutational screening is currently performed in familial cases only. Among the 90 distinct mutations found in the whole sample of families and isolated cases, definite pathogenicity is currently established for only 77%, emphasizing the need to pursue the effort to classify variants.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1002270

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052
APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy
Rovelet‐Lecrux, A., Hannequin, D., Raux, G., Meur, N. L., Laquerrière, A., Vital, A., Dumanchin‐Njock, C., Feuillette, S., Brice, A., Vercelletto, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1718 · Cited by 1,284
Self-citation
Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene
Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
Trafficking and Proteolytic Processing of APP
Haass, C., Kaether, C., Thinakaran, G., & Sisodia, S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006270 · Cited by 1,075
A framework for the interpretation of de novo mutation in human disease
Samocha, K. E., Robinson, E. B., Sanders, S. J., Stevens, C., Sabo, A., McGrath, L. M., Kosmicki, J. A., Rehnström, K., Mallick, S., Kirby, A., et al. (2014) · Nature Genetics · doi:10.1038/ng.3050 · Cited by 979
A Familial Alzheimer's Disease Locus on Chromosome 1
Levy‐Lahad, E., Wijsman, E. M., Nemens, E. J., Anderson, L., Goddard, K. A. B., Weber, J. L., Bird, T. D., & Schellenberg, G. D. (1995) · Science · doi:10.1126/science.7638621 · Cited by 832

Flagged first, then by citations

Show all 44 references

Sorted by citations

Items 501–600 of 614

Hétérogénéité génétique de la maladie d’Alzheimer : des mutations causales aux facteurs de risque génétiques rares et fréquents
Nicolas, G., & Wallon, D. (2017) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2017.01.020
Self-citation
HMGA1 zebrafish co-orthologue hmga1b can modulate p53-dependent cellular responses but is unable to control the alternative splicing of psen1Preprint
Nik, S. H. M., Newman, M., Lumsden, A. L., Jayne, T., & Lardelli, M. T. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/241927
Protein-Protein-Interaction Network and Pathway Analysis Related to Alzheimer’s Disease
徐, 煜. (2018) · Hans Journal of Biomedicine · doi:10.12677/hjbm.2018.82003
Cloning of Presenilin 2 cDNA and Construction of Vectors Carrying Effective Mutations in the Pathogenesis of Familial Alzheimer's Disease
Öztan, G., Yokeş, B., & İşsever, H. (2018) · Istanbul University - Journal of Electrical & Electronics Engineering · doi:10.26650/electrica.2018.12050
Molecular determinants of astrocyte morpho-functional changes in Alzheimer’s disease
Ulzheimer, N. E. (2019) · CLOK (University of Central Lancashire)
Personalized medicine. Precision medicine: PART B multifactorial diseases, genes, environments, interactions
Smith, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819613-7.00013-x
CERAMIDE-ENRICHED EXTRACELLULAR VESICLES
Elsherbini, A. M. (2020) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2020.474
Genetic Aspects of Early-Onset Alzheimer’s Disease
Boggula, V. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821974-4.00013-3
TREM2 Levels Are Increased in Neurodegenerative Disease Patients and in an Alzheimer's Disease Mouse ModelPreprint
Zhang, X., Liu, J., Cao, M., Yang, T., Wang, Y., Hou, Y., Song, Q., Cui, Y., & Wang, P. (2020) · doi:10.21203/rs.3.rs-71430/v1
Identifying and Ranking Potential Driver Genes of Alzheimer's Disease Using Weighted Co-Expression Network AnalysisPreprint
Xia, L.-Y., Tang, L., Huang, H. L., & Luo, J. (2021) · Research Square · doi:10.21203/rs.3.rs-529357/v1
An evaluation of the NCY Trust teenage parenting project
Porteous, D. J. (2010) · Middlesex University Research Repository (Middlesex University Of London)
Genotype
Tsui, N. B. Y., & Lau, J. Y. N. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_936
Mutation
Tsui, N. B. Y., & Lau, J. Y. N. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_937
A visual atlas of genes’ tissue-specific pathological rolesPreprint
Rai, P., Jain, A., Jha, N., Sharma, D., Kumar, S., Raj, A., Gupta, A., Poonia, S., Chawla, S., Majumdar, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.08.475476
Génétique de la maladie d’Alzheimer et des maladies apparentées : qu’en sait-on en 2022 ?
Formaglio, M., Ber, I. L., & Wallon, D. (2022) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2022.01.017 · Cited by 2
Self-citation
Deciphering the Molecular and Genetic Basis of Alzheimer’s Disease
Raghu, S. V., & Kudva, A. K. (2022) · Springer eBooks · doi:10.1007/978-981-16-6703-9_2
Generation of a human induced pluripotent stem cell (iPSC) line from skin fibroblasts of a patient carrying an E363Q mutation in PSEN1 gene
Zhu, W., Zhou, Y., Wang, Q., Li, J., Chu, S., Jin, W., Mao, C., Dong, L., Gao, J., & Xu, Q. (2022) · Stem Cell Research · doi:10.1016/j.scr.2022.102769
Estudo da correlação entre patologia amiloide cerebral e sintomas neuropsiquiátricos entre indivíduos com 50 anos ou mais
Saldanha, N. M. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2021.tde-31032022-162126
Identifying new genes and genetic factors causative of CADASIL and related stroke and dementia disorders
Dunn, P. J. (2022) · Queensland University of Technology · doi:10.5204/thesis.eprints.229972
Genotype
Tsui, N. B. Y., & Lau, J. Y. N. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_936-1
References
(2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811351-6.00026-7
Faculty Opinions recommendation of Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer's disease.
Ashford, J. W. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734280398.793553881
Mutation
Tsui, N. B. Y., & Lau, J. Y. N. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_937-1
MicroRNA s as Biomarker of Alzheimer’s Disease: Promises and Future Prospect
Singh, R. (2021) · Neurology & Neurotherapy Open Access Journal · doi:10.23880/nnoaj-16000158
Busca de pequenas moléculas naturais inibidoras da Rab10 para o tratamento da doença de Alzheimer
Alves, L. B. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2022.tde-08082022-110212
Familial Alzheimer’s disease mutation undermines axonal transport by enhancing dynactin recruitment to the APP motor assembliesPreprint
Feole, M., & Stokin, G. B. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.17.516829
Genetica della malattia di Alzheimer
Wallon, D., & Nicolas, G. (2022) · EMC - Neurologia · doi:10.1016/s1634-7072(22)47093-0
Self-citation
Detection of pathogenic variants in Alzheimer’s disease related genes in Bulgarian patients by pooled whole-exome sequencing
Karachanak-Yankova, S., Serbezov, D., Mihaylova, M., Nikolova, D. N., Balabanski, L., Damyanova, V., Antonova, O., Staneva, R., Ganev, M., Spasova, V., et al. (2023) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2022.2155572 · Cited by 1
Nanocarrier based drug delivery system – Future of Alzheimer disease
Sharma, J., Sunil, G., Amit, S., & Nitin, S. (2022) · Pharmaspire · doi:10.56933/pharmaspire.2022.14220
A multi-network approach to Alzheimer’s Disease gene prioritization complements cis -regulatory prioritization with molecular quantitative trait lociPreprint
Brabec, J. L., Lara, M. K., Tyler, A. L., & Mahoney, J. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.03.539189 · Cited by 1
A Brief Review on Alzheimer’s Disease
Suvitha, D., Dhivya, P., Saraswathy, T., & Ahamed Nisha, K. (2023) · International Journal of Pharmacy and Pharmaceutical Research · doi:10.25166/ijppr.2023.27.2.66
Late Age of Onset Predicted by Aβ Profiling in a Novel Psen1 (I180f) MutationPreprint
Robbie, L., Fernández, S. G., Montoya, L., Sagare, A. P., Barrera, L., Sheikh‐Bahaei, N., Gutiérrez, L. C., & Ringman, J. M. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4534203
Role of phospholipase A2 and glutamate in Alzheimer's disease
Samant, N. P., & Gupta, G. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-21800-2.00011-7
Rare A360T Mutation Alters GSK3β(Ser9) Binding in the Cytosolic Loop of Presenilin 1, Influencing β-Catenin Nuclear Localization and Pro-Death Gene Expression in Alzheimer’s Disease Case
Wężyk, M., Berdyński, M., Figarski, A., Skrzypczak, M., Ginalski, K., Zboch, M., Winkel, I., & Żekanowski, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316999
Genetic Testing in patients with Dementia: A Data-Driven Clinical Decision Tree for Memory ClinicsPreprint
van der Lee, S. J., Hulsman, M., van Spaendonk, R. M. L., van der Schaar, J., Dijkstra, J. I. R., Tesi, N., van Ruissen, F., Elting, M. W., Reinders, M. J. T., de Rojas, I., et al. (2024) · medRxiv · doi:10.1101/2024.01.14.24301065
Alzheimer’s Disease Classification Based on Demographic Data and Machine Learning
Almardoud, E. L. D., Tawfik, H., Mahmoud, S. A., & Hussain, A. J. (2023) · International Conference on Developments in eSystems Engineering (DeSE) · doi:10.1109/dese60595.2023.10469148
Spot the differences
Geut, A. J. (2024) · doi:10.5463/thesis.484
The Genetics of Alzheimer’s Disease and the role of non-long coding RNAs in disease pathogenesis
Roy, S., Biswas, S., Guha, D., Dasgupta, R., & Bagchi, A. (2024) · doi:10.52756/bhstiid.2024.e01.001
Strategies for precise regulation of autophagy by traditional Chinese medicine and natural products and their application in neurodegenerative disease models
Dong, Y. J., & Lu, J. (2024) · Scientia Sinica Vitae · doi:10.1360/ssv-2024-0039
In-silico virtual screening approaches and molecular dynamics simulation of quercetin derivatives for novel anti-Alzheimer drug candidates: Computational biology
Sharma, S., Johari, S., & Dang, S. (2024) · International Conference on Contemporary Computing · doi:10.1145/3675888.3676042
Exome analysis of 22,319 individuals links extremely rare CNVs and 22q11.21 dosage to Alzheimer’s riskPreprint
Quenez, O., Schramm, C., Cassinari, K., Nicolas, A., Groeneveld, J., Huguet, G., Grenier‐Boley, B., Hulsman, M., Walters, G. B., de Rojas, I., et al. (2024) · medRxiv · doi:10.1101/2024.10.28.24314051
Self-citation
A Neuroinflammatory View of Alzheimer’s Disease
Anisman, H., Hayley, S. P., & Kusnecov, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23565-8.00005-3
References
(2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23565-8.09996-8
Exploring the effect of temperature and peptide chain number on the stability of Aβ42 mutants through multidimensional analysis
Luo, S., Xu, X., Liu, J., Tang, B., Zhang, J. Z. H., & Duan, L. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.126562
The Role of Endoplasmic Reticulum Stress in Alzheimer's Disease: Molecular Mechanisms and Viral Hypotheses
Zhou, Y. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2024.19863
Alzheimer-mutant γ-secretase complexes stall amyloid β-peptide productionPreprint
Arafi, P., Devkota, S., Williams, E. M., Maesako, M., & Wolfe, M. S. (2025) · eLife · doi:10.7554/elife.102274.2
Alzheimer’s Disease Mutations Disrupt Neural Stem Cell Fate and Early Brain DevelopmentPreprint
Wang, Y., Lorentz, J., Mohammadi, E., Yilmaz, D. E., Sgouras, T., Guo, Y., Pizzirusso, G., Demetriou, A., Nalvarte, I., Schultzberg, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.16.643546 · Cited by 1
Presenilin 1 M139I mutation regulates the microRNA-34a-mediated neurogenic locus notch homolog protein 1 signaling pathway in an early-onset Alzheimer disease cell model
Sun, X., Dai, L., Yuan, X., Cheng, L., Wang, J., Tian, Y., & Zhou, L. (2025) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaf044
The Effects of Stress on Alzheimer’s Disease Development and Progression
Kalidindi, P. V. (2025) · American journal of student research. · doi:10.70251/hyjr2348.33716
Factors Affecting Global Video Game Sales Rankings: Analyzing the Impact of Platform, Genre, and Market Regions
Wang, Z. (2025) · American journal of student research. · doi:10.70251/hyjr2348.337280
Association between epigenetic mark 5-hydroxymethylcytosine and brain pathophysiology
Kang, A. K., Dhawan, U., & Mallick, B. N. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149755
Familial Alzheimer’s disease and Down syndrome
Castellani, R. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-99651-8.00022-3
Long Noncoding RNAs: Emerging Players in Neurodegenerative Diseases
Guha, P., Rishi, A., Bhat, N., & Mandal, S. S. (2025) · RNA technologies · doi:10.1007/978-3-031-91072-2_11
A novel PSEN2 mutation in amnestic early-onset Alzheimer's disease (EOAD): A familial case series
Leochico, C. F. D., Rogaeva, E. A., Zotovic, L., Oliveira, A. L. P., Le, T., Singnurkar, A., Masellis, M., & Mitchell, S. B. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251348676
Genomics and Transcriptomics of Alzheimer Disease
Vilor‐Tejedor, N., Rodríguez‐Fernández, B., Genius, P., Luckett, E. S., Anastasi, F., Lorenzini, L., Murray, H., Bull, C. J., Clement, M. H. S., Morris, A., et al. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_13
Biomarkers for Proteostasis Disruption: An Overview
Prakash, D., & Bisht, D. (2025) · Springer eBooks · doi:10.1007/978-981-96-6202-9_8
Planning for the future following receipt of Alzheimer's disease risk estimate among Latinos in New York City
Cabán, M., Tran, E., Meng, A., Wetmore, J. B., Ottman, R., & Siegel, K. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251365571
Interplay between circadian rhythms and epigenetics in neural stem cells and Alzheimer’s disease
Alves, T. C., Musílek, K., & Monti, B. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102808
From Imaging to Drug Delivery and Treatment
Mousavi-Sagharchi, S. M. A., Ranjbar-Jamalabadi, M., Yavari, S., Afrazeh, E., Poondla, N., & Sheykhhasan, M. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-0055-9.ch004
Genetically Modified Primate Models for Brain Disorder Research
Yang, Y., Lin, J., Li, M., Yang, L., Lu, Z., & Yan, T. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01529-7
Global, regional, and national burdens of early-onset Alzheimer's disease and other dementias in women, 1990 to 2021
Zhao, F., Li, Y., Yi, C., Li, X., Huang, G., Chen, X., Li, Y., & Zhang, J. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251395223
Resveratrol: A Stilbene with Multifaceted Roles in Alzheimer’s Disease
Nelson, V. K., Jayanthi, E. S. S. J. E. S. S., Gudimetla, K., Mayasa, V., Mandal, S. C., & Gopi, G. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2736-6_15
Carotenoids and Memory Enhancement: A Therapeutic Link to Alzheimer’s Disease
Choudhary, S., Aggarwal, N., & Bansal, S. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2736-6_12
Autophagy and Neuroinflammatory Pathways in Alzheimer’s Disease
Gupta, R. V., Pawar, J. S., Gujjari, L., & Kumari, S. (2025) · Springer eBooks · doi:10.1007/978-981-95-3945-1_8
Exercise and cognitive function in aging
Kabeer, D. A., Singh, P., Bhat, Z. U. H., Cherappurath, N., Ahmed, T., & Hassan, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36295-8.00007-9
Genetic influences on aging and neurodegenerative diseases
Rajalakshmi, D., Nisha, K., Hassan, S., Kumar, V. R., Faya, M., Mehdi, M. M., & Singh, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36295-8.00002-x
A Multi-Ancestry GWAS Meta-Analysis Integrated with In-Depth Silico, Systems Biology, and Pharmacogenomics Approaches on Alzheimer’s Disease Among 1,198,689 Subjects
Sharafshah, A., & Rezaei, S. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02452-2
Additional file 7 of A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects
Acosta-Uribe, J., Aguillón, D., Cochran, J. N., Giraldo, M., Madrigal, L., Killingsworth, B. W., Singhal, R., Labib, S., Alzate, D., Velilla, L. M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19327154
Additional file 1 of A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects
Acosta-Uribe, J., Aguillón, D., Cochran, J. N., Giraldo, M., Madrigal, L., Killingsworth, B. W., Singhal, R., Labib, S., Alzate, D., Velilla, L. M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19327136
Additional file 1 of Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes
Schramm, C., Charbonnier, C., Zaréa, A., Lacour, M., Wallon, D., Boland, A., Deleuze, J., Olaso, R., Alarcon, F., Campion, D., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20168234
Self-citation
Biosimilars: Antibody and nanobody-based therapeutic approaches towards protein misfolding diseases
Chinnathambi, S., & Rangappa, N. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.014
Radiogenomic Bipartite Graph Representation Learning for Alzheimer’s Disease Detection
Raj, A., & Mirzaei, G. (2026) · Lecture notes in computer science · doi:10.1007/978-3-032-09513-8_27
Neuroinflammatory Modulation and Potential Photocompounds
Anuradha, K., Perera, D., & Gunasekara, P. (2026) · Springer eBooks · doi:10.1007/978-981-95-4751-7_3
Longitudinal three-photon imaging for tracking amyloid plaques and vascular degeneration in a mouse model of Alzheimer’s disease
Stas, E., Yang, M., Schultz, S. R., & Go, M. A. (2026) · Journal of Biomedical Optics · doi:10.1117/1.jbo.31.1.016004
A novel TREM2 L15Q in signal peptide domain and its influence on Aβ pathogenicity
Kim, D., Bae, H., Shim, K. H., Yang, H., Jeong, D.-E., Kang, M. J., & An, S. S. A. (2026) · npj Dementia · doi:10.1038/s44400-025-00057-5
The future of transfusion and transplant microbiology safety: can new molecular technologies improve the safety of blood and transplant?
Peter Simmonds, K., & Harvala, H. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-12678-z
Responsible AI for Health Governance: A Focus on Alzheimer's Patients
Garg, M., Juneja, A., Painuli, D., Mishra, D., Kumari, P., & Kumar, V. (2025) · International Conference on Innovations and Emerging Technologies in AI & Communication Systems (IETACS) · doi:10.1109/ietacs68750.2025.11385450
Autophagy and neuroinflammation modulation by nano-graphene oxide in PSEN1 Alzheimer’s brain organoidsPreprint
Kim, N. G., Chun, J., Park, H., Kim, H., Choi, S. W., Ryu, J., & Kang, K. (2026) · Research Square · doi:10.21203/rs.3.rs-8383146/v1
Gut–brain Axis Modulation by Probiotics: Insights into Natural Remedies for Neurodegeneration
Nagesh, C. M., Prasad, A., Shivamallu, C., Shreevatsa, B., Prasad, M. L. R., Kollur, S. P., & Chakith, M. R. S. (2026) · Journal of Natural Remedies · doi:10.18311/jnr/2026/52726
Génération de cellules souches pluripotentes induites de patients Alzheimer et production d'un modèle de culture en trois dimensions de neurones pour les recherches diagnostiques et thérapeutiques de la maladie d’Alzheimer
Auboyer, L. (2018) · theses.fr (ABES) · doi:10.70675/07243ef7zb974z4ad8z97d9zd046801798b1
Variabilité inter et intra individuelle de la conscience des troubles et de soi dans la maladie d'Alzheimer
Mayelle, A. (2020) · doi:10.70675/8a3e0d11ze145z4e88zb8f3z1fadafe23b6c
Interconnection between Alzheimer’s disease and cardiovascular health: A narrative review of pathophysiological links and implications for treatment
Mani, R., Amo-Tweneboah, C., Kaiteris, A., Lebens, R. S., Chough, I., & Skopicki, H. A. (2026) · Aging advances. · doi:10.4103/agingadv.agingadv-d-25-00037
Maladies neurodégénératives et stress oxydant
Lévy, E. (2020) · theses.fr (ABES) · doi:10.70675/75371581z194fz4cb4zb457z91bf72dc0320 · Cited by 4
Diversité clinico-radiologique des microangiopathies cérébrales : Etude phénotypique et génétique de l’angiopathie amyloïde cérébrale et des calcifications cérébrales primaires
Grangeon, L. (2022) · theses.fr (ABES) · doi:10.70675/44d51667ze0fez4d16z9334zc48e6ea9d190
Etude des mécanismes physiοpathοlοgiques de la maladie d'Alzheimer : appοrt de l'étude des variants du gène SΟRL1
Castelot, R. (2024) · theses.fr (ABES) · doi:10.70675/c2a7ce1ez8caaz4593zbb3azae8add8055b5
The role of the α7 nicotinic acetylcholine receptor in a model of amyloid pathology
Santos, D. G. (2024) · theses.fr (ABES) · doi:10.70675/b3ed4de5zcd9ez4421za129z0a05130d86b9
Identification of inflammation‑related biomarkers for osteoarthritis diagnosis and stratification through bulk and single‑cell RNA‑sequencing integration
Xiao, J., Wang, W., Li, X., Xu, S., Zhang, B., & Liao, X. (2026) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2026.13164
Emerging Pharmacological Innovation in Alzheimer’s Treatment
Patel, A. K., Singh, M. P., Kumar, S., Kumar, S., Singh, N., Sachan, N., & Chandra, P. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814953126010013
Unraveling the anti-neuroinflammatory mechanisms of Cervus cucumis polypeptide injection in Alzheimer’s disease: insights from network pharmacology, molecular docking, molecular dynamics simulation, and experimental validation
Fu, X., Huang, J., Liu, Y., Li, H., & Zhang, Y. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1797302
Gene-Modulated Network Diffusion for Improved Modeling of Amyloid- β Spread in Alzheimer’s DiseasePreprint
Xu, F., Duong-Tran, D., Huang, H., Saykin, A. J., Thompson, P. M., Davatzikos, C. A., Zhao, Y., Shen, L., & Initiative, T. F. L. D. N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.04.722725
Nanotechnology for Alzheimer's disease: bridging pathobiology, delivery barriers and multi‐target therapy
M‐Atoom, A., Ahmed, M. H., Al-Hasnaawei, S., Malathi, H., Maharana, L., Nanda, A., Arora, V., & Singh‐Chauhan, A. (2026) · Polymer International · doi:10.1002/pi.70141
predALZ: An Ensemble Learning Framework for Identifying Genetic Biomarkers in Familial Alzheimer’s Disease
Karim, A., Alturise, F., Alkhalifah, T., & Khan, Y. D. (2026) · Current Drug Targets · doi:10.2174/0113894501408301251214192633
Assessing the de novo paradigm in sporadic early-onset Alzheimer disease trios
Zaréa, A., Cassinari, K., Lecoquierre, F., Quenez, O., Charbonnier, C., Schramm, C., Lacour, M., Rousseau, S., Richard, A., Rovelet‐Lecrux, A., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03665-6
Self-citation
Novel PSEN1 ( Q223 L ) mutation causes early-onset Alzheimer’s disease: A case report
Li, J., Zhou, F.-L., Chen, J.-J., Lin, Z.-J., Shi, X., Zhang, G.-G., Yang, H.-J., Dong, M., Yi, L., Hu, J., et al. (2026) · World Journal of Radiology · doi:10.4329/wjr.116652
Allele specific expression in Alzheimer's disease
Wang, Z., Hossain, D., Wang, J. J., Subramaniam, V. R., Zhang, B., Wang, M., & Huang, K. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71558
Angiopathie amyloïde cérébrale héréditaire
Grangeon, L., Nicolas, G., & Wallon, D. (2026) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(26)49255-6
Self-citation
Insulin resistance and obesity: Drivers of energy crisis for Alzheimer’s disease
Singh, P., Vaidya, B., Upadhayay, P., Sharma, S. S., & Datusalia, A. K. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.05.018
Mutations drive aberrant aggregation of proteins and nucleic acids in stress granules: Potential therapeutic targets for stress granule-mediated diseases
Gong, Y., Qu, M., Xu, Y., Bao, H., Shen, T., Zeng, L., Wu, X., & He, Q. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102333
Alzheimer Hastalığında NHE6
ALBAYRAK, İ. G. (2026) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.4278
A collaborative framework for uncovering molecular and cellular drivers of VCID: Foundations for future interventions in dementia
Iruela‐Arispe, M. L., Hinman, J. D., Yang, A. C., Dabertrand, F., Lee, J., & Howell, G. R. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71701

Authors: Lanoiselée, H.-M., Nicolas, G., Wallon, D., Rovelet-Lecrux, A., Lacour, M., Rousseau, S., Richard, A.-C., Pasquier, F., Rollin-Sillaire, A., Martinaud, O., Quillard-Muraine, M., de la Sayette, V., Boutoleau-Bretonniere, C., Etcharry-Bouyx, F., Chauviré, V., Sarazin, M., le Ber, I., Epelbaum, S., Jonveaux, T., Rouaud, O., Ceccaldi, M., Félician, O., Godefroy, O., Formaglio, M., Croisile, B., Auriacombe, S., Chamard, L., Vincent, J.-L., Sauvée, M., Marelli-Tosi, C., Gabelle, A., Ozsancak, C., Pariente, J., Paquet, C., Hannequin, D., Campion, D., & collaborators of the CNR-MAJ project
Affiliations: Inserm (FR)
Centre Hospitalier Universitaire d'Angers (FR)
Centre Hospitalier Sainte-Anne (FR)
Centre National de la Recherche Scientifique (FR)
Centre Hospitalier Régional et Universitaire de Nancy (FR)
CHU Dijon Bourgogne (FR)
Centre Hospitalier Universitaire Amiens-Picardie (FR)
Hospices Civils de Lyon (FR)
Centre Hospitalier Universitaire de Bordeaux (FR)
Centre Hospitalier Universitaire de Lille (FR)
Centre Hospitalier Universitaire de Grenoble (FR)
Centre Hospitalier Universitaire de Montpellier (FR)
Centre Hospitalier Universitaire de Toulouse (FR)
Corresponding author: Campion, Dominique
ORCID: Nicolas, Gaël
Wallon, David
Pasquier, Florence
Sarazin, Marie
Epelbaum, Stéphane
Jonveaux, Thérèse
Rouaud, Olivier
Ceccaldi, Mathieu
Félician, Olivier
Godefroy, Olivier
Croisile, Bernard
Sauvée, Mathilde
Gabelle, Audrey
Pariente, Jérémie
Paquet, Claire
Hannequin, Didier
Campion, Dominique
Venue: PLOS Medicine
Publisher: Public Library of Science (PLoS)
Published: 2017-03-28
Volume: 14
Issue: 3
Pages: e1002270
ISSN: 1549-1277 (ISSN-L)
1549-1676
DOI: 10.1371/journal.pmed.1002270
PMC: PMC5370101
OpenAlex: W2600872530
Cited by: 616
References: 44
Citations by year: 2026: 58 · 2025: 102 · 2024: 94 · 2023: 75 · 2022: 79 · 2021: 64 · 2020: 58 · 2019: 41 · 2018: 34 · 2017: 9
FWCI: 28.74
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (vor)
Locations: PLoS Medicine (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
HAL (submittedVersion, cc-by)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Figshare (submittedVersion, cc-by)
LillOA (Université de Lille (University Of Lille)) (submittedVersion, cc-by)
Funders: Clinical Research Hospital Program from the French Ministry of Health (GMAJ 2008/067)
French Ministry of Health (CNR-MAJ)
European Union (JPND PERADES, ANR-13-JPRF-0001-04)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: early-onset Alzheimer's disease, APP mutations, PSEN1 mutations, PSEN2 mutations, presenilin, amyloid precursor protein, novel mutations, de novo mutations, sporadic Alzheimer's disease, familial Alzheimer's disease, genetic screening, variant interpretation, cerebrospinal fluid biomarkers, total tau, phosphorylated tau, amyloid-beta 42, genetic counseling, mutation carriers
MeSH terms: Adult, Alzheimer Disease, Female, France, Genetic Testing, Humans, Male, Middle Aged, Mutation, Amyloid beta-Protein Precursor, Age of Onset, Presenilin-1, Presenilin-2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks